The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Granulocyte - colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim.
The global Filgrastim market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Filgrastim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Filgrastim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Filgrastim include Amgen, SANDOZ INC and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Filgrastim, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgrastim.
Report Scope
The Filgrastim market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Filgrastim market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Filgrastim manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
SANDOZ INC
Teva
Segment by Type
Lyophilized Powder
Others
Segment by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Filgrastim manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Filgrastim in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Granulocyte - colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim.
The global Filgrastim market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Filgrastim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Filgrastim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Filgrastim include Amgen, SANDOZ INC and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Filgrastim, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgrastim.
Report Scope
The Filgrastim market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Filgrastim market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Filgrastim manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
SANDOZ INC
Teva
Segment by Type
Lyophilized Powder
Others
Segment by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Filgrastim manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Filgrastim in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Filgrastim Market Overview
1.1 Product Overview and Scope of Filgrastim
1.2 Filgrastim Segment by Type
1.2.1 Global Filgrastim Market Value Comparison by Type (2024-2030)
1.2.2 Lyophilized Powder
1.2.3 Others
1.3 Filgrastim Segment by Application
1.3.1 Global Filgrastim Market Value by Application: (2024-2030)
1.3.2 Solid Tumor
1.3.3 Lymphoma
1.3.4 Kidney Cancer
1.3.5 Lung Disease
1.3.6 Others
1.4 Global Filgrastim Market Size Estimates and Forecasts
1.4.1 Global Filgrastim Revenue 2019-2030
1.4.2 Global Filgrastim Sales 2019-2030
1.4.3 Global Filgrastim Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Filgrastim Market Competition by Manufacturers
2.1 Global Filgrastim Sales Market Share by Manufacturers (2019-2024)
2.2 Global Filgrastim Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Filgrastim Average Price by Manufacturers (2019-2024)
2.4 Global Filgrastim Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Filgrastim, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Filgrastim, Product Type & Application
2.7 Filgrastim Market Competitive Situation and Trends
2.7.1 Filgrastim Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Filgrastim Players Market Share by Revenue
2.7.3 Global Filgrastim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Filgrastim Retrospective Market Scenario by Region
3.1 Global Filgrastim Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Filgrastim Global Filgrastim Sales by Region: 2019-2030
3.2.1 Global Filgrastim Sales by Region: 2019-2024
3.2.2 Global Filgrastim Sales by Region: 2025-2030
3.3 Global Filgrastim Global Filgrastim Revenue by Region: 2019-2030
3.3.1 Global Filgrastim Revenue by Region: 2019-2024
3.3.2 Global Filgrastim Revenue by Region: 2025-2030
3.4 North America Filgrastim Market Facts & Figures by Country
3.4.1 North America Filgrastim Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Filgrastim Sales by Country (2019-2030)
3.4.3 North America Filgrastim Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Filgrastim Market Facts & Figures by Country
3.5.1 Europe Filgrastim Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Filgrastim Sales by Country (2019-2030)
3.5.3 Europe Filgrastim Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Filgrastim Market Facts & Figures by Country
3.6.1 Asia Pacific Filgrastim Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Filgrastim Sales by Country (2019-2030)
3.6.3 Asia Pacific Filgrastim Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Filgrastim Market Facts & Figures by Country
3.7.1 Latin America Filgrastim Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Filgrastim Sales by Country (2019-2030)
3.7.3 Latin America Filgrastim Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Filgrastim Market Facts & Figures by Country
3.8.1 Middle East and Africa Filgrastim Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Filgrastim Sales by Country (2019-2030)
3.8.3 Middle East and Africa Filgrastim Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Filgrastim Sales by Type (2019-2030)
4.1.1 Global Filgrastim Sales by Type (2019-2024)
4.1.2 Global Filgrastim Sales by Type (2025-2030)
4.1.3 Global Filgrastim Sales Market Share by Type (2019-2030)
4.2 Global Filgrastim Revenue by Type (2019-2030)
4.2.1 Global Filgrastim Revenue by Type (2019-2024)
4.2.2 Global Filgrastim Revenue by Type (2025-2030)
4.2.3 Global Filgrastim Revenue Market Share by Type (2019-2030)
4.3 Global Filgrastim Price by Type (2019-2030)
5 Segment by Application
5.1 Global Filgrastim Sales by Application (2019-2030)
5.1.1 Global Filgrastim Sales by Application (2019-2024)
5.1.2 Global Filgrastim Sales by Application (2025-2030)
5.1.3 Global Filgrastim Sales Market Share by Application (2019-2030)
5.2 Global Filgrastim Revenue by Application (2019-2030)
5.2.1 Global Filgrastim Revenue by Application (2019-2024)
5.2.2 Global Filgrastim Revenue by Application (2025-2030)
5.2.3 Global Filgrastim Revenue Market Share by Application (2019-2030)
5.3 Global Filgrastim Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Filgrastim Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Filgrastim Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 SANDOZ INC
6.2.1 SANDOZ INC Corporation Information
6.2.2 SANDOZ INC Description and Business Overview
6.2.3 SANDOZ INC Filgrastim Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SANDOZ INC Filgrastim Product Portfolio
6.2.5 SANDOZ INC Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Filgrastim Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Filgrastim Product Portfolio
6.3.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Filgrastim Industry Chain Analysis
7.2 Filgrastim Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Filgrastim Production Mode & Process
7.4 Filgrastim Sales and Marketing
7.4.1 Filgrastim Sales Channels
7.4.2 Filgrastim Distributors
7.5 Filgrastim Customers
8 Filgrastim Market Dynamics
8.1 Filgrastim Industry Trends
8.2 Filgrastim Market Drivers
8.3 Filgrastim Market Challenges
8.4 Filgrastim Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
